{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:00:17Z","timestamp":1790503217211,"version":"4.1.0"},"reference-count":40,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T00:00:00Z","timestamp":1556928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Telomere dysfunction has been strongly implicated in the initiation of genomic instability and is suspected to be an early event in the carcinogenesis of human solid tumors. Recent findings have established the presence of telomere fusions in human breast and prostate malignancies; however, the onset of this genomic instability mechanism during progression of other solid cancers is not well understood. Herein, we explored telomere dynamics in patient-derived epithelial ovarian cancers (OC), a malignancy characterized by multiple distinct subtypes, extensive molecular heterogeneity, and widespread genomic instability. We discovered a high frequency of telomere fusions in ovarian tumor tissues; however, limited telomere fusions were detected in normal adjacent tissues or benign ovarian samples. In addition, we found relatively high levels of both telomerase activity and hTERT expression, along with anaphase bridges in tumor tissues, which were notably absent in adjacent normal ovarian tissues and benign lesions. These results suggest that telomere dysfunction may occur early in ovarian carcinogenesis and, importantly, that it may play a critical role in the initiation and progression of the disease. Recognizing telomere dysfunction as a pervasive feature of this heterogeneous malignancy may facilitate the future development of novel diagnostic tools and improved methods of disease monitoring and treatment.<\/jats:p>","DOI":"10.3390\/cells8050414","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T05:35:39Z","timestamp":1557725739000},"page":"414","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Onset of Telomere Dysfunction and Fusions in Human Ovarian Carcinoma"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7788-8621","authenticated-orcid":false,"given":"Nazmul","family":"Huda","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Bates","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Rankin","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Applied Biological Science, South Dakota School of Mines and Technology, Rapid City, SD 57701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8825-2178","authenticated-orcid":false,"given":"Nagarajan","family":"Kannan","sequence":"additional","affiliation":[{"name":"Division of Experimental Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gilley","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Applied Biological Science, South Dakota School of Mines and Technology, Rapid City, SD 57701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,5,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.genet.41.110306.130350","article-title":"How Shelterin Protects Mammalian Telomeres","volume":"42","author":"Palm","year":"2008","journal-title":"Annu. Rev. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.aab3389","article-title":"Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection","volume":"350","author":"Blackburn","year":"2015","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Watson, J.D. (1972). Origin of Cancatemeric T7 DNA. Nat. New Biol., 239.","DOI":"10.1038\/newbio239197a0"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/345458a0","article-title":"Telomeres Shorten during Ageing of Human Fibroblasts","volume":"345","author":"Harley","year":"1990","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrm2848","article-title":"Telomeres: Protecting chromosomes against genome instability","volume":"11","author":"Karlseder","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0959-437X(99)00047-7","article-title":"A Critical Role for Telomeres in Suppressing and Facilitating Carcinogenesis","volume":"10","author":"Artandi","year":"2000","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1158\/1541-7786.MCR-04-0194","article-title":"The Loss of a Single Telomere Can Result in Instability of Multiple Chromosomes in a Human Tumor Cell Line","volume":"3","author":"Sabatier","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/genetics\/26.2.234","article-title":"The Stability of Broken Ends of Chromosomes in Zea Mays","volume":"26","author":"McClintock","year":"1941","journal-title":"Genetics"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Bernal, A., and Tusell, L. (2018). Telomeres: Implications for Cancer Development. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010294"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1182\/blood-2010-02-272104","article-title":"Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: Evidence for a telomere crisis","volume":"116","author":"Lin","year":"2010","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"14098","DOI":"10.1073\/pnas.1120062109","article-title":"Telomere fusions in early human breast carcinoma","volume":"109","author":"Tanaka","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/mc.22326","article-title":"Widespread telomere instability in prostatic lesions","volume":"55","author":"Tu","year":"2016","journal-title":"Mol. Carcinog."},{"key":"ref_13","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"Ca: A Cancer J. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"(2011). Integrated Genomic Analyses of Ovarian Carcinoma. Nature, 474, 609\u2013615.","DOI":"10.1038\/nature10166"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2017.10.032","article-title":"Who are the long-term survivors of high grade serous ovarian cancer?","volume":"148","author":"Hoppenot","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1073\/pnas.1117135109","article-title":"High-grade serous ovarian cancer arises from fallopian tube in a mouse model","volume":"109","author":"Kim","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Labidi-Galy, S.I., Papp, E., Hallberg, D., Niknafs, N., Adleff, V., Noe, M., Bhattacharya, R., Novak, M., Jones, S., and Phallen, J. (2017). High grade serous ovarian carcinomas originate in the fallopian tube. Nat Commun, 8.","DOI":"10.1038\/s41467-017-00962-1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1128\/MCB.01569-08","article-title":"Altered States of Telomere Deprotection and the Two-Stage Mechanism of Replicative Aging","volume":"29","author":"Zou","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1474-9726.2007.00330.x","article-title":"Shared environmental factors associated with telomere length maintenance in elderly male twins","volume":"6","author":"Huda","year":"2007","journal-title":"Aging Cell"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1093\/nar\/gkn1027","article-title":"Telomere length measurement by a novel monochrome multiplex quantitative PCR method","volume":"37","author":"Cawthon","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"ref_22","first-page":"452","article-title":"Quantitation of hTERT Gene Expression in Sporadic Breast Tumors with a Real-Time Reverse Transcription-Polymerase Chain Reaction Assay","volume":"6","author":"Paradis","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/cbt.2.3.362","article-title":"Analysis of Anaphase Figures in Routine Histologic Sections Distinguishes Chromosomally Unstable from Chromosomally Stable Malignancies","volume":"2","author":"Montgomery","year":"2003","journal-title":"Cancer Biol. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/path.2704","article-title":"Q-FISH analysis of telomere and chromosome instability in the oesophagus with and without squamous cell carcinoma in situ","volume":"221","author":"Takubo","year":"2010","journal-title":"J. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/gcc.20425","article-title":"DNA repair pathways involved in anaphase bridge formation","volume":"46","author":"Acilan","year":"2007","journal-title":"Geneschromosomes Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bowtell, D.D.L. (2010). The Genesis and Evolution of High-Grade Serous Ovarian Cancer. Nat. Rev. Cancer, 10.","DOI":"10.1038\/nrc2946"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Lee, J.Y., Yoon, J.K., Kim, B., Kim, S., Kim, M.A., Lim, H., Bang, D., and Song, Y.S. (2015). Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing. Bmc Cancer, 15.","DOI":"10.1186\/s12885-015-1077-4"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/PAS.0b013e3181dcede7","article-title":"Shortened Telomeres in Serous Tubal Intraepithelial Carcinoma: An Early Event in Ovarian High-grade Serous Carcinogenesis","volume":"34","author":"Kuhn","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/jmedgenet-2012-100807","article-title":"Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases","volume":"49","author":"Yanowsky","year":"2012","journal-title":"J. Med Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1158\/1078-0432.CCR-12-3947","article-title":"Early Telomere Shortening and Genomic Instability in Tubo-Ovarian Preneoplastic Lesions","volume":"19","author":"Chene","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/gyno.2001.6483","article-title":"The relationship between telomere length and telomerase activity in gynecologic cancers","volume":"84","author":"Wang","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"ref_32","first-page":"5","article-title":"Telomerase Activity and Telomere Length as Diagnostic Tumor Marker for Ovarian Tumors","volume":"56","author":"Murakami","year":"1998","journal-title":"Nihon Rinsho."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Bordeira Gaspar, T., S\u00e1, A., Lopes, J.M., Sobrinho-Sim\u00f5es, M., Soares, P., and Vinagre, J. (2018). Telomere Maintenance Mechanisms in Cancer. Genes, 9.","DOI":"10.3390\/genes9050241"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.7544491","article-title":"The RNA component of human telomerase","volume":"269","author":"Feng","year":"1995","journal-title":"Science"},{"key":"ref_35","first-page":"645","article-title":"Human Telomerase RNA and Telomerase Activity in Immortal Cell Lines and Tumor Tissues","volume":"56","author":"Avilion","year":"1996","journal-title":"Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng1297-498","article-title":"Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT","volume":"17","author":"Weinrich","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.onc.1201882","article-title":"Telomerase activity is restored in human cells by ectopic expression of hTERT catalytic subunit of telomerase","volume":"16","author":"Counter","year":"1998","journal-title":"Oncogene"},{"key":"ref_38","first-page":"12","article-title":"Switching and Signaling at the Telomere","volume":"106","author":"Blackburn","year":"2001","journal-title":"Cell Cycle"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jclinpath-2018-205653","article-title":"TERT gene: Its function and dysregulation in cancer","volume":"72","author":"Colebatch","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12929-018-0422-8","article-title":"Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: Clinical impacts in cancer","volume":"25","author":"Lee","year":"2018","journal-title":"J. Biomed. Sci."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/5\/414\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:49:07Z","timestamp":1760186947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/5\/414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,4]]},"references-count":40,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["cells8050414"],"URL":"https:\/\/doi.org\/10.3390\/cells8050414","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,4]]}}}